Similarly, quantitative IHC of ATM in breast cancer identified a smaller subgroup of ATM-deficient patients [26] than does standard histopathology [27], however in both of these studies ATM-loss was associated with poor DFS. This evidence concerns the gene ATM and breast carcinoma.